Literature DB >> 12372313

Thoracic pain in a collegiate runner.

G P Austin1, W T Benesky.   

Abstract

This case study describes the process of examination, re-examination, and intervention for a collegiate runner with mechanical thoracic pain preventing athletic participation and limiting daily function. Unimpaired function fully returned in less than 3 weeks with biweekly sessions to re-establish normal and painfree thoracic mechanics via postural hygiene, exercise, mobilization, and manipulation. The outcome of this case study supports the original hypothesis that the pattern of impairments was in fact responsible for the functional limitations and disability in this athlete. At the time of publication the athlete was without functional limitations and had fully returned to competitive sprinting for the university track team.

Entities:  

Mesh:

Year:  2002        PMID: 12372313     DOI: 10.1054/math.2002.0461

Source DB:  PubMed          Journal:  Man Ther        ISSN: 1356-689X


  4 in total

1.  Characterizing negative reviews of orthopedic spine surgeons and practices.

Authors:  Joseph C Brinkman; Jordan R Pollock; Jaymeson R Arthur; Jacob Smith; Keldon Lin; Michael S Chang
Journal:  N Am Spine Soc J       Date:  2022-05-21

Review 2.  Thoracic spine pain in the general population: prevalence, incidence and associated factors in children, adolescents and adults. A systematic review.

Authors:  Andrew M Briggs; Anne J Smith; Leon M Straker; Peter Bragge
Journal:  BMC Musculoskelet Disord       Date:  2009-06-29       Impact factor: 2.362

3.  The use of functional and traditional mobilization interventions in a patient with chronic thoracic pain: a case report.

Authors:  David L Aiken; Dan Vaughn
Journal:  J Man Manip Ther       Date:  2013-08

4.  Thoracic spine manipulation for the management of mechanical neck pain: A systematic review and meta-analysis.

Authors:  Michael Masaracchio; Kaitlin Kirker; Rebecca States; William J Hanney; Xinliang Liu; Morey Kolber
Journal:  PLoS One       Date:  2019-02-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.